Overview Request Sample Pages Request Customization Download PDF
You are viewing: Kingdom Of Saudi Arabia Preimplantation Genetic Testing Market analysis

The Kingdom Of Saudi Arabia Preimplantation Genetic Testing Market was valued at $2.5 Million in 2025 and projected to reach to $4 Million by 2030, representing a compound annual growth rate of 10.3%. The Kingdom of Saudi Arabia's preimplantation genetic testing market is poised for sustained growth through 2030, supported by Vision 2030 healthcare modernization initiatives and increased private sector investment in fertility clinics.

Kingdom Of Saudi Arabia Preimplantation Genetic Testing Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Kingdom Of Saudi Arabia Preimplantation Genetic Testing Market Trends and Insights

  • This expansion reflects the Kingdom Of Saudi Arabia's increasing investment in advanced reproductive healthcare technologies and rising awareness among fertility clinics and patients regarding genetic screening benefits.
  • The Kingdom Of Saudi Arabia's market growth is driven by improving healthcare infrastructure, growing disposable incomes, and enhanced access to assisted reproductive technologies across major urban centers. In the Kingdom Of Saudi Arabia, the adoption of preimplantation genetic testing is accelerating due to supportive regulatory frameworks and the country's commitment to modernizing its healthcare sector.
  • The Kingdom Of Saudi Arabia's fertility clinics are increasingly integrating PGT services to improve success rates and reduce genetic disorder transmission.
  • Between 2025 and 2030, the Kingdom Of Saudi Arabia market will benefit from technological advancements, increased clinical awareness, and growing patient demand for personalized reproductive medicine solutions..

Key Market Statistics

  • CAGR (2025-2030) 10.3% CAGR
  • Market Size, 2025 ~USD 2.5 Million
  • Forecast, 2030 ~USD 4 Million
  • Country Kingdom Of Saudi Arabia

Kingdom Of Saudi Arabia Preimplantation Genetic Testing Market Overview

Market Valuation Growth :

The Kingdom of Saudi Arabia's PGT market is valued at USD 2.5 million in 2025, with projections reaching USD 4.0 million by 2030, demonstrating a strong 10.3% CAGR driven by healthcare modernization initiatives.

Government Healthcare Investment :

Saudi Arabia's Vision 2030 agenda prioritizes advanced reproductive healthcare technologies, with increased government funding supporting fertility clinics and genetic testing infrastructure across major cities like Riyadh and Jeddah.

Rising Fertility Awareness :

Growing awareness among Saudi couples regarding genetic screening benefits, combined with improved accessibility to PGT services, is driving market expansion and adoption rates in the Kingdom.

Regional Healthcare Hub Status :

Saudi Arabia is positioning itself as a regional medical tourism destination, attracting patients from neighboring Gulf states seeking advanced reproductive genetic testing services and expertise.

Kingdom Of Saudi Arabia Preimplantation Genetic Testing Market Dynamics

  • Enhanced regulatory frameworks and government support for reproductive health technologies are creating favorable conditions for market expansion.
  • Rising disposable incomes and growing awareness of genetic screening benefits among Saudi couples are driving demand for advanced PGT services.
  • The market is expected to benefit from technological advancements and increased collaboration between local healthcare providers and international fertility specialists, positioning Saudi Arabia as a leading regional hub for reproductive genetic testing..

Related Ecosystem

Advanced Genetic Sequencing

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Reagents
  • Assay Kits
  • Bioinformatics
  • Flow Cytometry
Top Companies
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • Agilent Technologies, Inc.
  • Qiagen N.V.
  • Danaher Corporation

    Biotechnology

    Top Technologies
    • Reagents
    • Polymerase Chain Reaction (PCR)
    • Stem Cells
    • Assay Kits
    • Flow Cytometers
    Top Companies
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Danaher Corporation
    • Agilent Technologies, Inc.
    • Bio-Rad Laboratories, Inc.

      Key Takeaways

      • Kingdom Of Saudi Arabia's PGT market is valued at USD 2.5 million in 2025 and will reach USD 4.0 million by 2030.
      • The Kingdom Of Saudi Arabia market is growing at a 10.3% CAGR, driven by advanced healthcare infrastructure and rising fertility awareness.
      • Kingdom Of Saudi Arabia's regulatory support and modernization initiatives are accelerating PGT adoption among fertility clinics.
      • The Kingdom Of Saudi Arabia's growing middle class and disposable incomes are increasing demand for advanced reproductive healthcare services.

      Preimplantation Genetic Testing Market Report Scope

      Report Metric Details
      Base Year 2025
      Fastest Growing Segment SINGLE GENE DISORDERS (Application)
      Forecast Period 2025–2030
      Growth Rate CAGR of 10.5% from 2025 to 2030
      Largest Segment PREIMPLANTATION GENETIC SCREENING (Procedure Type)
      Market Size Base Year (Billions) ~USD 0.69 (2025)
      Revenue Forecast (Billions) ~USD 1.14 (2030)
      Segments Covered Product & Service, Procedure Type, Technology, Application, Type, Type Of Cycle, End User

      Kingdom Of Saudi Arabia Preimplantation Genetic Testing Market Report Segmentation

      7 segment dimensions are covered across the global market.

      By Product & Service

      • Instruments
      • Reagents & Consumables
      • Software & Services

      By Procedure Type

      • Preimplantation Genetic Diagnosis
      • Preimplantation Genetic Screening

      By Technology

      • Comparative Genomic Hybridization
      • Fluorescence In Situ Hybridization
      • Next-Generation Sequencing
      • Polymerase Chain Reaction
      • Single-Nucleotide Polymorphism

      By Application

      • Aneuploidy
      • Gender Identification
      • Hla Typing
      • Single Gene Disorders
      • Structural Chromosomal Abnormalities
      • X-Linked Disorders

      By Type

      • Deletions
      • Duplications
      • Inversions
      • Translocations

      By Type Of Cycle

      • Fresh Donor
      • Fresh Non-Donor
      • Frozen Donor
      • Frozen Non-Donor

      By End User

      • Diagnostic Laboratories
      • Fertility Clinics
      • Hospitals
      • Other End Users

      Target Audience

      • Fertility Clinic Operators : Clinic owners and reproductive healthcare providers need market data to assess expansion opportunities, benchmark services, and understand local demand drivers for PGT offerings in Saudi Arabia.
      • Medical Device & Diagnostic Companies : PGT technology manufacturers and diagnostic firms require market insights to identify distribution partnerships, pricing strategies, and growth opportunities within the Kingdom's healthcare ecosystem.
      • Healthcare Investors & PE Firms : Investment professionals evaluating reproductive healthcare opportunities in Saudi Arabia need market sizing, growth projections, and competitive analysis to support investment decisions.
      • Government & Healthcare Policy Makers : Saudi health ministry officials and policy advisors require market intelligence to align Vision 2030 initiatives with actual market dynamics and optimize healthcare infrastructure investments.
      • International Healthcare Consultants : Consulting firms advising clients on Middle East market entry need Saudi Arabia-specific PGT data to develop localized strategies and identify market opportunities for reproductive health services.

      Key Companies in the Kingdom Of Saudi Arabia Preimplantation Genetic Testing Market

      CompanyHQOwnershipStrongest segments
      CIMARON LABELPressure-sensitive paper labels,Film and durable labels,Specialty/custom applications,
      THERMO FISHER SCIENTIFIC INC.United StatesPublic CompanyLaboratory Products and Biopharma Services,Life Sciences Solutions,Analytical Instruments,
      AGILENT TECHNOLOGIES, INC.United StatesPublic CompanyLife Sciences and Diagnostics Markets,Agilent CrossLab,Applied Markets,
      REVVITYUnited StatesPublic CompanyReagents, Assays, and Consumables,Instruments and Detection/Imaging Platforms,Software, Subscriptions, and Informatics,
      COOPERCOMPANIESUnited StatesPublic CompanySpherical contact lenses,Toric and multifocal contact lenses,Fertility consumables, equipment, and services,
      ABBOTTUnited StatesPublic CompanyDiagnostic Products,Medical Devices,Nutritional Products,
      TAKARA BIO INC.JapanPrivate CompanyResearch reagents for genetic and cellular research,Instruments (PCR instruments and cellular analysis devices),In vitro diagnostics (including COVID-19 testing),
      VITROLIFESwedenPublic CompanyIVF media and oil,Labware (dishes, pipettes, tubes, VitroTemp, eWitness-related consumables),Cryopreservation solutions,

      CIMARON LABEL

      Insufficient information provided to generate description.

      THERMO FISHER SCIENTIFIC INC.

      Thermo Fisher Scientific Inc. is a United States-based public company founded in 1956 with 125,000 employees. The company is a global leader in serving science, providing laboratory equipment, reagents, and analytical instruments.

      AGILENT TECHNOLOGIES, INC.

      Agilent Technologies, Inc. is a United States-based public company founded in 1999 with 18,000 employees. The company provides life sciences, diagnostics, and applied chemical markets with instruments and software.

      REVVITY

      Revvity is a United States-based public company founded in 1937 with 11,000 employees. The company provides analytical technologies and solutions for research, diagnostics, and applied markets.

      COOPERCOMPANIES

      CooperCompanies is a United States-based public company founded in 1958 with 15,000 employees. The company operates in the medical device sector, primarily focused on contact lenses and eye care products.

      ABBOTT

      Abbott is a United States-based public company founded in 1888 with 115,000 employees. The company is a diversified healthcare manufacturer producing pharmaceuticals, diagnostics, nutritional products, and medical devices.

      TAKARA BIO INC.

      Takara Bio Inc. is a Japan-based private company founded in 2002 with 1,779 employees. The company specializes in biotechnology research and development.

      VITROLIFE

      Vitrolife is a Sweden-based public company founded in 1989 with 1,103 employees. The company develops and manufactures products for assisted reproduction and embryo culture.

      Reasons to Buy this Report

      • Market-Specific Growth Projections : Access detailed forecasts showing Saudi Arabia's PGT market expanding from USD 2.5M to USD 4.0M by 2030, enabling precise investment and expansion planning tailored to Kingdom-specific growth trajectories.
      • Regulatory & Policy Insights : Understand Saudi Arabia's Vision 2030 healthcare framework, government incentives, and regulatory environment shaping PGT market dynamics, helping stakeholders navigate local compliance requirements.
      • Competitive Landscape Analysis : Identify key players, market consolidation trends, and competitive positioning within Saudi Arabia's fertility sector, enabling strategic partnerships and market entry strategies.
      • Demand Driver Understanding : Gain insights into Saudi consumer behavior, awareness levels, and adoption patterns specific to genetic testing, informing targeted marketing and service development strategies.
      • Regional Hub Opportunity Assessment : Evaluate Saudi Arabia's potential as a medical tourism destination for PGT services, identifying cross-border demand opportunities and revenue expansion possibilities from neighboring Gulf markets.

      Frequently asked questions

      What is the current market size of preimplantation genetic testing in the Kingdom Of Saudi Arabia?

      The Kingdom Of Saudi Arabia preimplantation genetic testing market is valued at USD 2.5 million in 2025.

      What is the projected market size for the Kingdom Of Saudi Arabia PGT market by 2030?

      The Kingdom Of Saudi Arabia PGT market is projected to reach USD 4.0 million by 2030.

      What is the CAGR for the Kingdom Of Saudi Arabia preimplantation genetic testing market?

      The Kingdom Of Saudi Arabia PGT market is expected to grow at a compound annual growth rate of 10.3% from 2025 to 2030.

      What factors are driving growth in the Kingdom Of Saudi Arabia PGT market?

      Growth in the Kingdom Of Saudi Arabia is driven by improved healthcare infrastructure, rising patient awareness, supportive regulatory frameworks, and increasing adoption of assisted reproductive technologies.

      How is the Kingdom Of Saudi Arabia positioned within the GCC PGT market?

      The Kingdom Of Saudi Arabia represents a significant market within the GCC region, with strong growth potential supported by healthcare modernization initiatives and increasing fertility clinic adoption of PGT services.

      RESEARCH METHODOLOGY

      This research extensively used secondary sources, directories, and databases to gather valuable information for analyzing the global preimplantation genetic testing market. In-depth interviews were conducted with various primary respondents, including key industry players, subject-matter experts (SMEs), C-level executives, and industry consultants, to obtain and verify important qualitative and quantitative data and evaluate the market’s growth prospects. The global market size estimated through secondary research was cross-checked with inputs from primary research to determine the final market size.

      Secondary Research

      Secondary research was mainly used to gather information for the detailed technical, market, and commercial analysis of the preimplantation genetic testing market. The secondary sources for this study include the World Health Organization (WHO), World Bank, Human Fertilization and Embryology Authority (HFEA), International Federation of Fertility Societies (IFFS), American Society for Reproductive Medicine (ASRM), Australia and New Zealand Assisted Reproduction Database (ANZARD), Centers for Disease Control and Prevention (CDC), Society for Assisted Reproductive Technology (SART), National Health Service (NHS), Indian Fertility Society (IFS), British Fertility Society (BFS), European Society of Human Reproduction and Embryology (ESHRE), Association for Fertility and Reproductive Health (AFRH), German Society of Reproductive Medicine (DGRM), Canadian Fertility & Andrology Society (CFAS), Indian Society for the Study of Reproduction and Fertility (ISSRF), Spanish Fertility Society (Sociedad Española de Fertilidad-SEF), Japan Society for Reproductive Medicine, National Registry of Assisted Reproductive Technology and Surrogacy Registry, Journal of Human Reproductive Sciences, American Congress of Obstetricians and Gynecologists (ACOG), European Society of Human Genetics (ESHG); ACS Journals; corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; research journals; press releases; and trade, business, and professional associations.

      Secondary data was collected and analyzed to determine the overall size of the global preimplantation genetic testing market, which was then validated through primary research. These sources also provided key information about major players, market classification, and segmentation based on industry trends, regional and country-level markets, market developments, and technological perspectives.

      Primary Research

      In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the market’s prospects. Various primary sources from the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information.

      Preimplantation Genetic Testing Market

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      The top-down and bottom-up approaches were used to estimate & validate the total size of the preimplantation genetic testing market. These methods were also used extensively to estimate the size of various market segments.

      Preimplantation Genetic Testing Market

      Data Triangulation

      After evaluating the overall market size through the market size estimation process, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were used, whenever applicable, to complete the overall market engineering process and obtain precise statistics for all segments and subsegments. The data was triangulated by analyzing various factors and trends from the demand and supply sides.

      Market Definition

      Preimplantation genetic testing (PGT) examines embryos during in vitro fertilization (IVF) before possible transfer to a woman's uterus. This is done to test a range of genetic problems that can cause implantation failure, miscarriage, and birth defects in a resulting child.

      Preimplantation genetic testing refers to the three types of tests that may be performed on embryos during IVF:

      • Preimplantation genetic screening for abnormal chromosome number (PGT-A)
      • Preimplantation genetic testing for monogenic (individual) disease (PGT-M)
      • Preimplantation genetic testing structural rearrangement (PGT-SR) for known chromosomal misarrangements such as inversion and translocation.

      The study offers an in-depth analysis of the preimplantation genetic testing market, examining contemporary market trends and developments, as well as its potential growth from 2025 to 2030. It includes detailed market trends, the competitive landscape, market size, forecasts, and the analysis of the key preimplantation genetic testing product and service providers.

      Stakeholders

      • Contract research organizations (CROs)
      • Contract development and manufacturing organizations (CDMOs)
      • In vitro fertilization (IVF) centers and fertility clinics
      • Life science companies
      • Fertility clinics
      • Academic & research institutes
      • Private research institutes
      • Venture capitalists & investors
      • Market research & consulting firms
      • Government associations
      • Medical institutions & universities
      • Hospitals & clinics

      Report Objectives

      • To define, describe, and forecast the preimplantation genetic testing market based on procedure type, technology, product & service, application, type of cycle, end user, and region
      • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
      • To strategically analyze micromarkets concerning individual growth trends, prospects, and contributions to the overall preimplantation genetic testing market
      • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
      • To forecast the size of the market segments concerning six main regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
      • To strategically profile the key players in the preimplantation genetic testing market and comprehensively analyze their core competencies and market rankings
      • To track and analyze competitive developments such as product launches, acquisitions, expansions, agreements, partnerships, and collaborations in the preimplantation genetic testing market
      • To benchmark players within the preimplantation genetic testing market using the ‘Company Evaluation Matrix' framework, which analyzes market players based on various parameters within the broad categories of business and product strategy

      Get the Full Preimplantation Genetic Testing Market Report

      Full forecast, segment splits, and company analysis for all Preimplantation Genetic Testing Market.

      Download Sample Pages Buy Report

      METHODOLOGY

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      Cite this Research
      DMCA.com Protection Status